To address the nationwide concern of costly immunotherapy agents, this article features health system inpatient and outpatient strategies that can help mitigate their costs.
Carina Verdier Dolan, PharmD, BCOP
Advertisement
Articles by Carina Verdier Dolan, PharmD, BCOP
Advertisement
Latest Updated Articles
- Evolving Practices in Managing Costly Immunotherapy
Published: February 8th 2016 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
Government Shutdown Could Disrupt Health Care Access
2
Colon Cancer Recurrence Risk Nearly Gone After 6 Years, Study Reveals
3
Maternal, Child Mortality Higher in the US Compared With Majority of High-Income Countries
4
Lurbinectedin Combo Approved by FDA for Extensive-Stage Small Cell Lung Cancer
5
